ArticleWorld journal of urology2025
Outcomes of Percutaneous Nephrolithotomy in Kidney Transplant Recipients: Results from a Multicenter Study by the Spanish Urology Association's Renal Transplant Group.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionStone disease amongst kidney transplant recipients (KTR) may not only lead to significant morbidity but also compromise graft function. In this context, percutaneous nephrolithotomy (PCNL) has emerged as a fundamental minimally invasive surgical technique for the treatment of kidney stones in KTR. The aim of this study is to evaluate the outcomes of PCNL in KTR in a nationwide series, encompassing operative results, stone-free rate (SFR), stone composition and renal graft function. MATERIALS &
methodsRetrospective data from five Spanish tertiary hospitals was analysed. All KTR that underwent PCNL between January 2005 and August 2024 were included in the study. Stone characteristics, postoperative complications, and surgical outcomes were evaluated.
resultsThe study included 39 KTR, median age 59 (32-82) years, predominantly male (71.8%). Most KTR received grafts from cadaveric donors (n = 35). Even though stone diagnosis was often incidental (64.1%), 74.3% of KTR experienced stone-related events before surgery, such as acute kidney failure (53.8%) and sepsis (15.4%). Diagnosis occurred after a median of 53 (0-264) months post-transplant. Preoperative nephrostomy insertion was common (59.0%), and 48.7% of KTR had positive urine cultures. Median stone size was 14 (5-50) mm with 53.8% of KTR having multiple stones. Median stone density was 720 (130-1770) HU. Overall complication rate after PCNL was 10.2%: 2 patients presented with urinary septic shock, 1 patient experienced puncture site bleeding requiring embolization and 1 haematuria accompanied by acute renal failure. Stone-free rate was 82.0% in the first procedure, with secondary treatments being successful when needed. The most frequent stone composition was calcium oxalate monohydrate (55.2%).
conclusionsIn our experience, PCNL is an effective and safe technique for addressing nephrolithiasis in KTR. SFR and complication rates may be comparable to those reported in PCNL performed in native kidneys. Furthermore, patients tend to benefit from surgical care in high-volume centres that possess dedicated expertise in both KT and endourology.
Indexed as
Identifiers
40974439What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.